SABSW — SAB BIOTHERAPEUTICS INC
As of Q2 2026, 3 SEC-registered investment managers reported holding SABSW (SAB BIOTHERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.76K across 215.51K shares. That is +1.1% by share count (+2.38K shares) versus the previous quarter, while reported value moved -49.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
SABSW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $1.87K | 0.00% | Hold |
| Millennium Management history | 62.50K | $800 | 0.00% | Hold |
| UBS Group AG history | 6.57K | $85 | 0.00% | Add |
Q1 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $3.71K | 0.00% | Hold |
| Millennium Management history | 62.50K | $1.63K | 0.00% | Hold |
| UBS Group AG history | 4.19K | $105 | 0.00% | Reduce |
Q4 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $4.57K | 0.00% | Hold |
| Millennium Management history | 62.50K | $1.95K | 0.00% | Hold |
| UBS Group AG history | 6.19K | $192 | 0.00% | Reduce |
| Bank of America Corp history | 100 | $3 | 0.00% | Reduce |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $3.43K | 0.00% | Hold |
| Millennium Management history | 62.50K | $1.46K | 0.00% | Hold |
| UBS Group AG history | 23.41K | $539 | 0.00% | New |
| Bank of America Corp history | 200 | $5 | 0.00% | New |
Q2 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $4.88K | 0.00% | Hold |
| Millennium Management history | 62.50K | $2.08K | 0.00% | Hold |
Q1 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 146.44K | $3.81K | 0.00% | Hold |
| Millennium Management history | 62.50K | $2.18K | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 150.85K | 31.41K |
| Millennium Management | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K |
| UBS Group AG | 6.57K | 4.19K | 6.19K | 23.41K | — | — | 1.63K | — | 56 | — | 29.08K | — | 100 | — | — | 5.61K | — | — | 2.89K |
| Bank of America Corp | — | — | 100 | 200 | — | — | — | — | 200 | 100 | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 19.91K | 18.71K | 19.49K | 19.63K |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 18.35K |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 281.11K | 281.11K | 281.11K | 281.11K | 281.11K | 281.11K |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 247.58K | 285.00K | 285.00K | 285.00K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details